Table of Content

1. Product Overview
1.1. Indication
1.2. Mechanism of Action
1.3. Dosage and Administration
1.4.1 Dosage Forms and Strengths
1.4. Route of Synthesis
1.5. Pharmacology
1.4.2 Pharmacodynamics
1.4.3 Pharmacokinetics
1.6. Adverse Reactions
1.7. Product Snapshot
1.8. Development Milestones of Tenofovir alafenamide
1.9. Marketed Details
1.4.4 United States
1.4.5 Europe
1.4.6 Japan
1.10. Patent Details

2. SWOT Analysis
2.1. Analyst Views

3. Regulatory Milestones
3.1. Approvals
3.2. Research and Development
3.3. Clinical Trials Information
3.4. Safety and Efficacy
3.5. Product Developmental Activities

4. Market Assessment
4.1. 7MM Market Analysis
4.2. United States
4.3. Europe
4.4. Japan
4.5. Key Findings

5. Market Competitors

6. Emerging Therapies

7. Appendix
7.1. Report Purchase Options



List of Figures


Figure 1 The Development Timeline of Tenofovir alafenamide
Figure 2 Patent Details, Tenofovir alafenamide
Figure 3 Tenofovir alafenamide, 7MM Market Size from 2017 to 2030 (in Million USD)
Figure 4 Tenofovir alafenamide, US Market Size from 2017 to 2030 (in Millions USD)
Figure 5 Tenofovir alafenamide, EU Market Size from 2017 to 2030 (in Millions USD)
Figure 6 Tenofovir alafenamide, EU5 Market Size from 2017 to 2030 (in Millions USD)
Figure 7 Tenofovir alafenamide, Japan Market Size from 2017 to 2030 (in Millions USD)


List of Tables


Table 1 Tenofovir alafenamide, Description
Table 2 Tenofovir alafenamide, Trial Diversification
Table 3 Tenofovir alafenamide, Marketed Details United States
Table 4 Tenofovir alafenamide, Marketed Details Europe
Table 5 Tenofovir alafenamide, Marketed Details Japan
Table 6 Patent Details: Tenofovir alafenamide
Table 7 Tenofovir alafenamide, Clinical Trial Description, 2020
Table 8 Safety and Efficacy Results for Tenofovir alafenamide
Table 9 Tenofovir alafenamide, 7MM Market Size from 2017 to 2030 (in Million USD)
Table 10 Tenofovir alafenamide, US Market Size from 2017 to 2030 (in Million USD)
Table 11 Tenofovir alafenamide, EU Market Size from 2017 to 2030 (in Million USD)
Table 12 Tenofovir alafenamide, EU5 Market Size from 2017 to 2030 (in Millions USD)
Table 13 Tenofovir alafenamide, Japan Market Size from 2017 to 2030 (in Million USD)
Table 14 Market Competitors
Table 15 Emerging Therapies